logo-large
  • Browse Categories

Publications by authors named "Montaser Namnah"

Claim this Profile
S
Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease.
Eduard Linetsky, Suaad Abd Elhadi, Max Bauer, Akiva Gallant, Montaser Namnah

Front Neurol· January 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa-responsive dystonia caused by biallelic exon inversion invisible to exome sequencing.
Hagar Mor-Shaked, Emuna Paz-Ebstein, Adily Basal, Simona Ben-Haim, Hanna Grobe, Montaser Namnah

Brain Commun· September 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benign SLC39A14 Course of Dystonia-Parkinsonism Secondary to Inherited Manganese Accumulation.
Montaser Namnah, Max Bauer, Hagar Mor-Shaked, Susan B Bressman, Deborah Raymond

Mov Disord Clin Pract· July 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reader response: Peripheral synucleinopathy in a DJ1 patient with Parkinson disease, cataracts, and hearing loss.
Montaser Namnah, Orly Elpeleg, Marc Gotkine, David Arkadir

Neurology· May 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: